{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:54:16Z","timestamp":1786992856871,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["F31 GM119345"],"award-info":[{"award-number":["F31 GM119345"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["F31 GM131635"],"award-info":[{"award-number":["F31 GM131635"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM135919"],"award-info":[{"award-number":["R01 GM135919"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI085051"],"award-info":[{"award-number":["R01 AI085051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jmb.2022.167503","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T10:57:49Z","timestamp":1645095469000},"page":"167503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug Resistance"],"prefix":"10.1016","volume":"434","author":[{"given":"Jacqueto","family":"Zephyr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desaboini","family":"Nageswara Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang V.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klajdi","family":"Kosovrasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Matthew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K.","family":"Hedger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Timm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nese","family":"Kurt Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia A.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jmb.2022.167503_b0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory HCVC","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"32","key":"10.1016\/j.jmb.2022.167503_b0010","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","article-title":"Chronic hepatitis C and liver fibrosis","volume":"20","author":"Sebastiani","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1 Suppl","key":"10.1016\/j.jmb.2022.167503_b0015","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jhep.2016.07.035","article-title":"The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control","volume":"65","author":"Bukh","year":"2016","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jmb.2022.167503_b0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.30647","article-title":"Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants","volume":"70","author":"Jensen","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jmb.2022.167503_b0025","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/acschembio.5b00647","article-title":"Structural and Thermodynamic Effects of Macrocyclization in HCV NS3\/4A Inhibitor MK-5172","volume":"11","author":"Soumana","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.jmb.2022.167503_b0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/acschembio.9b00675","article-title":"Molecular and Structural Mechanism of Pan-Genotypic HCV NS3\/4A Protease Inhibition by Glecaprevir","volume":"15","author":"Timm","year":"2020","journal-title":"ACS Chem. Biol."},{"issue":"7","key":"10.1016\/j.jmb.2022.167503_b0035","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1021\/cb400100g","article-title":"Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3\/4A protease inhibitors to drug resistance","volume":"8","author":"Ali","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"16","key":"10.1016\/j.jmb.2022.167503_b0040","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.bmcl.2019.03.037","article-title":"Discovery of the pan-genotypic hepatitis C virus NS3\/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi((R))","volume":"29","author":"Taylor","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.jmb.2022.167503_b0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cbic.200301023","article-title":"Fluorine in medicinal chemistry","volume":"5","author":"Bohm","year":"2004","journal-title":"ChemBioChem"},{"issue":"14","key":"10.1016\/j.jmb.2022.167503_b0050","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J. Med. Chem."},{"issue":"51","key":"10.1016\/j.jmb.2022.167503_b0055","doi-asserted-by":"crossref","first-page":"11797","DOI":"10.1002\/chem.201901840","article-title":"Fluorine-Containing Drugs Approved by the FDA in 2018","volume":"25","author":"Mei","year":"2019","journal-title":"Chemistry"},{"issue":"3","key":"10.1016\/j.jmb.2022.167503_b0060","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1021\/acs.jmedchem.9b01769","article-title":"Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel","volume":"63","author":"Kang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmb.2022.167503_b0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jfluchem.2016.07.020","article-title":"Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ","volume":"196","author":"Ojima","year":"2017","journal-title":"J. Fluor. Chem."},{"issue":"9","key":"10.1016\/j.jmb.2022.167503_b0070","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jfluchem.2008.05.013","article-title":"Syntheses and Structure-Activity Relationships of Novel 3'-Difluoromethyl and 3'-Trifluoromethyl-Taxoids","volume":"129","author":"Kuznetsova","year":"2008","journal-title":"J. Fluor. Chem."},{"issue":"12","key":"10.1016\/j.jmb.2022.167503_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1039\/C4SC01626B","article-title":"Synthesis, broad spectrum antibacterial activity, and X-ray co-crystal structure of the decoding bacterial ribosomal A-site with 4\u2032-deoxy-4\u2032-fluoro neomycin analogs","volume":"5","author":"Hanessian","year":"2014","journal-title":"Chem. Sci."},{"issue":"9","key":"10.1016\/j.jmb.2022.167503_b0080","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/cb5003416","article-title":"Toxicity modulation, resistance enzyme evasion, and A-site X-ray structure of broad-spectrum antibacterial neomycin analogs","volume":"9","author":"Maianti","year":"2014","journal-title":"ACS Chem. Biol."},{"issue":"8","key":"10.1016\/j.jmb.2022.167503_b0085","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1021\/acschembio.6b00315","article-title":"Harnessing Fluorine-Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs","volume":"11","author":"Bauer","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.jmb.2022.167503_b0090","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1039\/B711844A","article-title":"Understanding organofluorine chemistry. An introduction to the C-F bond","volume":"37","author":"O'Hagan","year":"2008","journal-title":"Chem. Soc. Rev."},{"issue":"17","key":"10.1016\/j.jmb.2022.167503_b0095","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1021\/acs.jmedchem.6b00821","article-title":"Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing","volume":"59","author":"Sun","year":"2016","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.jmb.2022.167503_b0100","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1021\/acs.orglett.5b01216","article-title":"Toward the Synthesis of Fluorinated Analogues of HCV NS3\/4A Serine Protease Inhibitors Using Methyl alpha-Amino-beta-fluoro-beta-vinylcyclopropanecarboxylate as Key Intermediate","volume":"17","author":"Milanole","year":"2015","journal-title":"Org. Lett."},{"issue":"23","key":"10.1016\/j.jmb.2022.167503_b0105","doi-asserted-by":"crossref","first-page":"14740","DOI":"10.1021\/acs.jmedchem.0c01296","article-title":"Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3\/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection","volume":"63","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"issue":"49","key":"10.1016\/j.jmb.2022.167503_b0110","doi-asserted-by":"crossref","first-page":"20986","DOI":"10.1073\/pnas.1006370107","article-title":"Drug resistance against HCV NS3\/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding","volume":"107","author":"Romano","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.jmb.2022.167503_b0115","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1021\/acs.jmedchem.7b00426","article-title":"Hepatitis C Virus NS3\/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants","volume":"60","author":"Matthew","year":"2017","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.jmb.2022.167503_b0120","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00172-20","article-title":"Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3\/4A Protease Inhibitors","volume":"11","author":"Matthew","year":"2020","journal-title":"mBio"},{"issue":"16","key":"10.1016\/j.jmb.2022.167503_b0125","doi-asserted-by":"crossref","first-page":"11972","DOI":"10.1021\/acs.jmedchem.1c00554","article-title":"Discovery of Quinoxaline-Based P1\u2013P3 Macrocyclic NS3\/4A Protease Inhibitors with Potent Activity Against Drug-Resistant HCV Variants","volume":"64","author":"Nageswara Rao","year":"2021","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.jmb.2022.167503_b0130","article-title":"Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3\/4A Protease","volume":"26","author":"Matthew","year":"2018","journal-title":"Structure (London, England: 1993)"},{"issue":"38","key":"10.1016\/j.jmb.2022.167503_b0135","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1002\/anie.200460781","article-title":"A weak attractive interaction between organic fluorine and an amide group","volume":"43","author":"Hof","year":"2004","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"12","key":"10.1016\/j.jmb.2022.167503_b0140","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/anie.200462213","article-title":"Orthogonal multipolar interactions in structural chemistry and biology","volume":"44","author":"Paulini","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"5","key":"10.1016\/j.jmb.2022.167503_b0145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1039\/b312188g","article-title":"The observation of a large gauche preference when 2-fluoroethylamine and 2-fluoroethanol become protonated","volume":"2","author":"Briggs","year":"2004","journal-title":"Org. Biomol. Chem."},{"issue":"5","key":"10.1016\/j.jmb.2022.167503_b0150","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/jo302265k","article-title":"Intimate interactions with carbonyl groups: dipole-dipole or n\u2013>pi*?","volume":"78","author":"Kamer","year":"2013","journal-title":"J. Org. Chem."},{"issue":"21","key":"10.1016\/j.jmb.2022.167503_b0155","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1021\/jm0498349","article-title":"Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field","volume":"47","author":"Carosati","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.jmb.2022.167503_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002832","article-title":"The molecular basis of drug resistance against hepatitis C virus NS3\/4A protease inhibitors","volume":"8","author":"Romano","year":"2012","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.jmb.2022.167503_b0165","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1021\/cb5006118","article-title":"Structural analysis of asunaprevir resistance in HCV NS3\/4A protease","volume":"9","author":"Soumana","year":"2014","journal-title":"ACS Chem. Biol."},{"issue":"9","key":"10.1016\/j.jmb.2022.167503_b0170","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1023\/A:1011625728803","article-title":"Van der Waals Radii of Elements","volume":"37","author":"Batsanov","year":"2001","journal-title":"Inorg. Mater."},{"issue":"18","key":"10.1016\/j.jmb.2022.167503_b0175","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1021\/acs.jmedchem.5b00975","article-title":"Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes","volume":"58","author":"Pollock","year":"2015","journal-title":"J. Med. Chem."},{"issue":"5846","key":"10.1016\/j.jmb.2022.167503_b0180","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in pharmaceuticals: looking beyond intuition","volume":"317","author":"Muller","year":"2007","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jmb.2022.167503_b0185","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01249-18","article-title":"Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials","volume":"62","author":"Krishnan","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jmb.2022.167503_b0190","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01620-17","article-title":"In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3\/4A Protease Inhibitor Glecaprevir","volume":"62","author":"Ng","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.jmb.2022.167503_b0195","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40265-018-0895-5","article-title":"Sofosbuvir\/Velpatasvir\/Voxilaprevir: A Review in Chronic Hepatitis C","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.jmb.2022.167503_b0200","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1021\/cb400100g","article-title":"Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3\/4A protease inhibitors to drug resistance","volume":"8","author":"Ali","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jmb.2022.167503_b0205","unstructured":"M. Wittekind, S. Weinheirner, Y. Zhang, V. Goldfarb, US Patent 6333186, (2002)."},{"issue":"7","key":"10.1016\/j.jmb.2022.167503_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002832","article-title":"The molecular basis of drug resistance against hepatitis C virus NS3\/4A protease inhibitors","volume":"8","author":"Romano","year":"2012","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.jmb.2022.167503_b0215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/abio.1998.3014","article-title":"Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction","volume":"267","author":"Liu","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jmb.2022.167503_b0220","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"issue":"Pt 4","key":"10.1016\/j.jmb.2022.167503_b0225","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"issue":"Pt 12 Pt 1","key":"10.1016\/j.jmb.2022.167503_b0230","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"2","key":"10.1016\/j.jmb.2022.167503_b0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"suppl 2","key":"10.1016\/j.jmb.2022.167503_b0240","doi-asserted-by":"crossref","first-page":"W375","DOI":"10.1093\/nar\/gkm216","article-title":"MolProbity: all-atom contacts and structure validation for proteins and nucleic acids","volume":"35","author":"Davis","year":"2007","journal-title":"Nucl. Acids Res."},{"issue":"6359","key":"10.1016\/j.jmb.2022.167503_b0245","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/355472a0","article-title":"Free R value: a novel statistical quantity for assessing the accuracy of crystal structures","volume":"355","author":"Brunger","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2022.167503_b0250","unstructured":"Anonymous (PyMOL: The PyMOL Molecular Graphics System, Version 1.8, Schr\u00f6dinger, LLC)."},{"issue":"10","key":"10.1016\/j.jmb.2022.167503_b0255","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/JVI.02531-09","article-title":"Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance","volume":"84","author":"Nalam","year":"2010","journal-title":"J. Virol."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283622000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283622000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:47:00Z","timestamp":1758318420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283622000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0022283622000778"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2022.167503","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.30.470632","asserted-by":"object"}]},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug Resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2022.167503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"167503"}}